The Annual General Meeting 2024 took place on Wednesday, March 13, 2024, at 2:00 PM CET at the Copenhagen Marriott Hotel, Kalvebod Brygge 5, 1560 Copenhagen, Denmark.
To replay the webcast of the Annual General Meeting, please use one of the following links:
Please click on the links below for information concerning Genmab A/S’ Annual General Meeting 2024.
• Shareholder letter
• Notice of Annual General Meeting 2024 with agenda, including Appendix 1: Candidates for the Board of Directors and Appendix 2: Remuneration Policy
• Register online or use the registration form
• Submit proxy or postal vote online or use the form to submit proxy or postal vote
• 2023 Annual Report of Genmab A/S
• 2023 Compensation Report
The total number of voting rights and total share capital per February 15, 2024, is:
Total Number of Voting Rights: 66,074,535
Total Share Capital: 66,074,535
Questions regarding registration to participate may be directed to Euronext Securities at tel. no. (+45) 43 58 88 94 or [email protected].
Vice President,
Head of Investor Relations
Telephone: +45 3377 9558
Email: [email protected]
Carl Jacobsens Vej 30
2500 Valby
Denmark
We process your personal data in accordance with applicable rules. Please click here to read our Privacy Policy.
Please note that Genmab A/S, as a general rule, no longer sends the calling to Annual General Meetings by postal mail. If you wish to receive the invitation to future Annual General Meetings via e-mail, please register your e-mail address at the InvestorPortal. If you do not have access to an e-mail address, please contact Euronext Securities at: (+45) 43 58 88 66.
Read about Genmab’s purpose, core values and key accomplishments
See the results of innovation that is rooted in science
We are developing next-generation technologies